Table 2:

Results of the regression analyses evaluating whether thalamic susceptibility is associated with baseline characteristics

	Before Adjustment for Covariates			After Adjustment for Covariates
	Coefficient	95% CI	P Value	Coefficient	95% CI	P Value
Presence of enhancing lesions	8.40	0.41–16.40	.04^{^a}	10.68	2.28–19.09	.013^{^a}
Age	0.19	−0.037–0.42	.099	0.27	0.031–0.52	.02^{^a}
Sex	0.75	−4.36–5.85	.77	1.45	−3.69–6.58	.58
Use of disease-modifying therapies	−0.57	−5.46–4.32	.82	0.44	−4.43–5.32	.86
Disease duration	−0.023	−0.33–0.28	.88	−0.066	−0.39–0.26	.69